Jayaprakash K. Nair
42Patents
9h-index
36Co-inventors
71Inventor score
Filing activity: Jan 11, 2012 → Mar 4, 2024
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US9352048B2 | Carbohydrate conjugates as delivery agents for oligonucleotides | Emerging Cross-Sectional Technologies | 99 | Active |
| US9682922B2 | Biodegradable lipids for the delivery of active agents | Chemistry; Metallurgy | 36 | Active |
| US9682139B2 | Lipids and compositions for the delivery of therapeutics | Emerging Cross-Sectional Technologies | 28 | Active |
| US9867882B2 | Carbohydrate conjugates as delivery agents for oligonucleotides | Emerging Cross-Sectional Technologies | 23 | Active |
| US9370581B2 | Carbohydrate conjugates as delivery agents for oligonucleotides | Emerging Cross-Sectional Technologies | 18 | Active |
| US9370582B2 | Carbohydrate conjugates as delivery agents for oligonucleotides | Emerging Cross-Sectional Technologies | 17 | Active |
| US11504391B1 | Modified RNA agents with reduced off-target effect | Chemistry; Metallurgy | 12 | Active |
| US9999673B2 | PEGylated lipids and their use for drug delivery | Chemistry; Metallurgy | 11 | Active |
| US10117941B2 | Lipids and compositions for the delivery of therapeutics | Emerging Cross-Sectional Technologies | 10 | Active |
| US9566340B2 | Monomers and oligonucleotides comprising cycloaddition adduct(s) | Emerging Cross-Sectional Technologies | 9 | Active |
| US10806791B2 | Carbohydrate conjugates as delivery agents for oligonucleotides | Emerging Cross-Sectional Technologies | 8 | Active |
| US9764036B2 | Lipids and compositions for the delivery of therapeutics | Emerging Cross-Sectional Technologies | 7 | Active |
| US9814777B2 | Targeting lipids | Emerging Cross-Sectional Technologies | 7 | Active |
| US10995336B2 | Serpina1 iRNA compositions and methods of use thereof | Chemistry; Metallurgy | 6 | Active |
| US10086081B2 | Carbohydrate conjugated RNA agents and process for their preparation | Emerging Cross-Sectional Technologies | 4 | Active |
| US10821186B2 | Lipids and compositions for the delivery of therapeutics | Emerging Cross-Sectional Technologies | 4 | Active |
| US11597932B2 | Chirally-enriched double-stranded RNA agents | Chemistry; Metallurgy | 3 | Active |
| US11110174B2 | Carbohydrate conjugates as delivery agents for oligonucleotides | Emerging Cross-Sectional Technologies | 2 | Active |
| US10808246B2 | Oligonucleotide-ligand conjugates and process for their preparation | Chemistry; Metallurgy | 1 | Active |
| US11420931B2 | Lipid containing formulations | Human Necessities | 1 | Active |
| US11725207B2 | Serpina1 iRNA compositions and methods of use thereof | Chemistry; Metallurgy | 1 | Active |
| US9701623B2 | Di-aliphatic substituted pegylated lipids | Chemistry; Metallurgy | 1 | Active |
| US11053495B2 | Multi-targeted single entity conjugates | Chemistry; Metallurgy | 0 | Active |
| US12173288B2 | Oligonucleotide-ligand conjugates and process for their preparation | Chemistry; Metallurgy | 0 | Active |
| US12005074B2 | Extrahepatic delivery | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.